Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bangalore
Clinical trial register · India

Clinical Trials in Bangalore, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1120 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:16 UTC
1120
Studies in scope
all four open statuses
608
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
New Delhi 339 Mumbai 260 Hyderabad 233 Bangalore 199 Pune 186
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca41 Eli Lilly and Company16 Novartis Pharmaceuticals11 Novo Nordisk A/S11 Janssen Research & Development, LLC9
Site location
New Delhi339 Mumbai260 Hyderabad233 Bangalore199 Pune186
All 274 locations
Target enrolment
to

Trials with a site in Bangalore

199 of 1120 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Qurse Revand for MASLD: A Randomized Controlled Safety and Efficacy Trial
NCT07902219MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
National Institute of Unani Medicine, Bengaluru
Phase 2
128
Bangalore
2027-05-01
Not yet open
Comparative Study on Unani Formulation Vs Active Control in Plaque Psoriasis
NCT07841314Chronic Plaque Psoriasis, Plaque Psoriasis, Psoriasis, Taqashshur al Jild
National Institute of Unani Medicine, Bengaluru
Phase 2
54
Bangalore
2027-04-01
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Belagavi, Nagpur, Pune, New Delhi, Dehradun, Kolkata, Ahemdabad, Bangalore
2026-12-16
Not yet open
Eli Lilly and Company
Phase 4
50
Bangalore, Hyderabad, Kolkata, Mumbai, New Delhi, Tamil Nadu, Vellore
2026-11
Recruiting
Novo Nordisk A/S
Phase 3
84
Guwahati, Kozhikode, New Delhi, Bhubaneswar, Hyderabad, Bangalore
2026-10-16
Recruiting
Clinical Evaluation of a Novel Trifocal IOL
NCT07587138Aphakia, Cataract
Alcon Research
Not applicable
66
Chennai, Bangalore
2026-10-09
Not yet open
Indira IVF Hospital Pvt Ltd
Not applicable
830
Patna, Bangalore, Bhāndup, Pune, Delhi, Jaipur, Udaipur, Allahābād
2026-10-05
Not yet open
Jawaharlal Institute of Postgraduate Medical Education & Research
Phase 3
220
Bangalore, Udupi, Mumbai, Bhubaneswar, Puducherry
2026-10
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Ahmedabad, Bangalore, Gūrgaon, Kottayam, Madurai, Nashik, New Delhi, Vadodara
2026-09-24
Recruiting
AstraZeneca
Phase 3
1,330
Ansārinagar, Bangalore, Delhi, Kannur, Nagpur, New Delhi, Vadodara
2026-09-15
Recruiting
Amazentis SA
Not applicable
90
Bangalore
2026-08-26
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Guntur, Raipur, Surat, Vadodara, Bangalore, Kochi, Kozhikode, Indore
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Aligarh, Bangalore, Belagavi, Bhubaneswar, Calicut, Chennai, Dehradun, Delhi
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,500
Bangalore, Indore, Kolkata, Nagpur, Noida, Pune, Siliguri, Visakhapatnam
2026-08-20
Recruiting
Eli Lilly and Company
Phase 2
606
Ahmedabad, Allahabād, Bangalore, Bhopal, Chhatrapati Sambhajinagar, Lucknow, Nagpur, New Delhi
2026-08-07
Recruiting
Novo Nordisk A/S
Phase 3
80
Guntur, Surat, Bangalore, New Delhi, Delhi, Kanpur, Kolkata, Kolhāpur
2026-08-04
Recruiting
Boehringer Ingelheim
Phase 3
448
Bangalore, Bhubaneswar, Gurugram, Hyderabad, Kochi, Maharashtra, New Delhi
2026-07-27
Recruiting
Pfizer
Phase 4
60
Visakhapatnam, Gurugram, Bangalore, Mangalore, Nashik, Thane, Kolkata
2026-07-24
Not yet open
Indira IVF Hospital Pvt Ltd
Not applicable
860
Patna, Bangalore, Bhāndup, Pune, Delhi, Jaipur, Allahābād, Lucknow
2026-07-17
Recruiting
AstraZeneca
Phase 3
600
Bangalore, Belagavi, Chennai, Coimbatore, Guntur, Hyderabad, Indore, Kochi
2026-07-08
Recruiting
AstraZeneca
Phase 3
2,000
Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Guwahati, Indore, Jaipur
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Bangalore, Belagavi, Bikaner, Delhi, Guntur, Hyderabad, Jaipur, Jodhpur
2026-06-29
Recruiting
Pfizer
Phase 3
540
Visakhapatnam, Bangalore, Belagavi, Nashik, Pune, Dwarka, New Delhi, Jaipur
2026-06-22
Not yet open
Clinical Thresholds of Double-strand Breaks in Sperm's DNA in ART
NCT07621991Sperm DNA Fragmentation, Sperm DNA Impact on ART Outcomes
Indira IVF Hospital Pvt Ltd
Observational
484
Bangalore, Pune
2026-06-01
Not yet open
Novo Nordisk A/S
Phase 3
1,000
Guntur, Surat, Vadodara, Bangalore, Bengaluru, Kochi, Indore, Mumbai
2026-05-20
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Guntur, Vijayawada, Raipur, Vadodara, Gurgaon, Gurugram, Bangalore, Belagavi
2026-05-11
Recruiting
AstraZeneca
Observational
2,150
Guntur, Guwahati, Bangalore, Belagavi, Calicut, Kochi, Thiruvananthapuram, Indore
2026-05-06
Recruiting
AstraZeneca
Phase 3
670
Bangalore, Gūrgaon, Navi Mumbai
2026-05-04
Recruiting
Laboratoires Thea
Phase 2
120
Kolkata, Ahmedabad, Bangalore, Hyderabad, Jaipur, Patna, Pune, Surat
2026-03-24
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Patna, Ahmedabad, Bangalore, Belagavi, Mysore, Nashik
2026-03-09
Recruiting
Bristol-Myers Squibb
Phase 1
46
Hyderabad, Ahmedabad, Bangalore, Mysuru, Nagpur, Pune, Bhubaneswar, Secunderabad
2026-02-27
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Bikaner, Calicut, Chandigarh, Coimbatore
2026-02-17
Recruiting
Eli Lilly and Company
Phase 3
900
Allahabād, Bangalore, Chennai, Hyderabad, Jaipur, Kanpur, Kolhāpur, Mysore
2026-02-10
Recruiting
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NCT07209917Cervical Cancer, Human Papillomavirus (HPV) Infection, Human Immunodeficiency Virus (HIV) Infection
University of California, Irvine
Not applicable
348
Bangalore, Bengaluru
2026-02-01
Recruiting
Sun Pharmaceutical Industries Limited
Phase 2
285
Guntur, Bangalore, Kozhikode, Trivandrum, Kolhāpur, Mumbai, Pune, New Delhi
2026-01-20
Recruiting
AstraZeneca
Phase 4
166
Bangalore, Dalgate, Drugjan, Hyderabad, Lucknow, Nagpur, New Delhi
2026-01-20
Recruiting
Novo Nordisk A/S
Phase 3
460
Guntur, Surat, Bangalore, New Delhi, Delhi, Kanpur, Kolkata, Kolhāpur
2026-01-08
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Surat, Vadodara, Gurugram, Bangalore, Belagavi, Kottayam, Nagpur, Nashik
2026-01-06
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Bangalore, Bengaluru, Mumbai, Nashik, New Delhi, Varanasi, Hyderabad
2026-01-02
Recruiting
Eli Lilly and Company
Phase 3
1,035
Bangalore
2025-12-15
Recruiting
Eli Lilly and Company
Phase 3
7,140
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Guntur, Hubli, Hyderabad, Kanpur
2025-12-01
Recruiting
AstraZeneca
Phase 3
400
Bangalore, Kolkata, Mumbai, Nashik, New Delhi
2025-10-31
Recruiting
Daiichi Sankyo
Phase 3
686
Bangalore, Bhubaneswar, Howrah, Mangalore, Pune, Surat
2025-10-24
By invitation
Body Fat Reduction and Weight Management
NCT07378033Obesity & Overweight
Bioagile Therapeutics Pvt. Ltd.
Not applicable
100
Bangalore
2025-10-23
Recruiting
Eli Lilly and Company
Phase 2
531
Bangalore, Bhubaneswar, Chhatrapati Sambhajinagar, Dwārka, Kanpur, New Delhi, Pune, Raipur
2025-10-22
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bangalore, Bengaluru, Bhubaneswar, Gurugram, Hyderabad, Jaipur, Kochi, Ludhiana
2025-10-03
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Bangalore, Bengaluru, Bhubaneswar, Ernākulam, Gurugram, Hyderabad, Jaipur, Ludhiana
2025-10-01
By invitation
Bioagile Therapeutics Pvt. Ltd.
Not applicable
46
Bangalore
2025-09-16
By invitation
Bioagile Therapeutics Pvt. Ltd.
Not applicable
46
Bangalore
2025-09-10
Recruiting
Alcon Research
Observational
400
Bangalore
2025-07-30
Recruiting
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
NCT07217392Bradycardia, Right Ventricular Pacing, Heart Failure, Atrial Fibrillation (AF)
Abbott Medical Devices
Not applicable
200
Bangalore, New Delhi, Madurai, Kolkata
2025-07-24
Recruiting
AstraZeneca
Phase 3
15,100
Ahmedabad, Bangalore, Belagavi, Bikaner, Calicut, Chennai, Chhatrapati Sambhajinagar, Coimbatore
2025-06-04
Recruiting
Assessing Safety and Performance of the Novel CytaCoat Foley Catheter
NCT07070921Safety of the CytaCoat Foley Catheter, Performance of the CytaCoat Foley Catheter
CytaCoat AB
Not applicable
30
Bangalore
2025-06-02
Not yet open
St. John's Research Institute
Not applicable
1,560
Bangalore
2025-06-01
Active, closed
Johnson & Johnson Private Limited
Phase 4
75
Bangalore, Bengaluru, Chandigarh, Jaipur, Kolkata, Mumbai, Nagpur, New Delhi
2025-05-22
Recruiting
Biogen
Phase 3
180
Hyderabad, Bangalore, Pune, New Delhi, Lucknow, Varanasi, Kolkata, Chandigarh
2025-05-22
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bangalore, Bikaner, Chennai, Chhatrapati Sambhajinagar, Kochi, Kolkata, Nashik, New Delhi
2025-05-20
Recruiting
Biogen
Phase 3
454
Hyderabad, Raipur, Ahmedabad, Nadiād, Bangalore, Kozhikode, Trivandrum, Mumbai
2025-05-08
Recruiting
AstraZeneca
Phase 3
1,220
Ahmedabad, Bangalore, Binnāguri, Dehradun, Delhi, Hyderabad, Mumbai, Nashik
2025-05-06
Recruiting
Indian Council of Medical Research
Not applicable
1,650
Bangalore, Bhopal
2025-05-01
Not yet open
Sudhir Srivastava Innovations Pvt. Ltd.
Observational
365
Bangalore
2025-05
Active, closed
Eli Lilly and Company
Phase 3
487
Bangalore, Bhubaneswar, New Delhi, Ulhasnagar
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Bangalore, Bhubaneswar, New Delhi, Ulhasnagar
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Bangalore, Bhubaneswar, New Delhi, Ulhasnagar
2025-04-30
Active, closed
Immutep S.A.S.
Phase 3
756
Bangalore, Bhubaneswar, Chennai, Kolkata, New Delhi, Thane, Thiruvananthapuram, Varanasi
2025-03-21
Recruiting
AstraZeneca
Phase 3
11,300
Ahmedabad, Ajmer, Bangalore, Belagavi, Dehradun, Delhi, Gūrgaon, Hyderabad
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Bangalore, Belagavi, Hyderabad, Kolkata, Madurai, Mumbai, New Delhi, Pune
2025-03-03
Recruiting
AstraZeneca
Phase 3
840
Ansārinagar, Bangalore, Delhi, Hyderabad, Kolkata, Mumbai, Varanasi
2025-03-01
Not yet open
Unilever R&D
Not applicable
34
Bangalore
2025-03
By invitation
Novo Nordisk A/S
Observational
244
Bangalore
2025-01-31
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
40
Vadodara, Jhajjar, Bangalore, Chhatrapati Sambhajinagar, Nagpur, Pune, Satara, Thane
2025-01-15
Recruiting
Novo Nordisk A/S
Phase 3
480
Raipur, Mumbai, Bangalore, Gujarat, Maharashtra, New Delhi
2025-01-10
Active, closed
Pfizer
Phase 3
1,035
Surat, Gurugram, Bangalore, Mumbai, Nashik, Pune, Thane, New Delhi
2025-01-06
Active, closed
AstraZeneca
Phase 4
100
Bangalore, Delhi, Kochi, Mumbai, New Delhi, Pune, Varanasi
2025-01-02
Recruiting
GlaxoSmithKline
Phase 3
520
Ahmedabad, Bangalore, Hyderabad, Kolkata, Pune, Sushrut Hospital and Research
2024-12-16
Recruiting
St. John's Research Institute
Phase 2/3
120
Bangalore
2024-11-15
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Bangalore, Bathinda, Bhubaneswar, Bilāspur, Chandigarh, Chennai, Dwārka, Faridabad
2024-08-30
Recruiting
Takeda
Phase 4
124
Vijayawada, Guwahati, Surat, Bangalore, Puducherry, Nashik, Navi Mumbai, Pune
2024-08-28
Recruiting
Jubilant Therapeutics India Limited
Phase 1
30
Surat, Bangalore, Mumbai, Nashik, Thane, New Delhi
2024-08-26
Recruiting
Colorado Prevention Center
Phase 3
1,500
Ahmedabad, Bangalore, Nagpur, New Delhi
2024-07-09
Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
NCT06466135Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease, Primary Immunoglobulin A Nephropathy
Walden Biosciences
Phase 2
96
Raipur, Nadiād, Vadodara, Bangalore, Pune, Sambhajinagar, New Delhi, Patparganj
2024-07-02
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Hyderabad, Bangalore, Mangalore, Nashik, Pune
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Ahmedabad, Bangalore, Dehradun, Delhi, Gurugram, Hyderabad, Kolkata, Lucknow
2024-06-20
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bangalore, Bengaluru, Bikaner, Chennai, Chhatrapati Sambhajinagar, Guwahati, Gūrgaon, Kochi
2024-06-17
Active, closed
GlaxoSmithKline
Phase 3
88
Gokul Shirgoan, Apex Wellness Hospital, Bangalore, Belagavi, Bhubaneswar, Gūrgaon, New Delhi
2024-06-10
Active, closed
Eli Lilly and Company
Phase 3
10,000
Allahabād, Bangalore, Bhubaneswar, Bikaner, Chennai, Dehradun, Guntur, Kanpur
2024-04-30
Recruiting
Octapharma
Phase 3
124
Pune, Bangalore, Chhatrapati Sambhajinagar, Patna
2024-04-30
Recruiting
AstraZeneca
Phase 3
582
Bangalore, Delhi, Hyderabad, Kolkata, Mysuru, Nagpur, Nashik, New Delhi
2024-04-29
Recruiting
Seung-Jung Park
Not applicable
960
Bangalore
2024-04-25
Active, closed
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
NCT06256432Hepatorenal Syndrome, Liver Cirrhosis, Acute Kidney Injury, Ascites Hepatic
DrugsAmbrisentan·Terlipressin
Noorik Biopharmaceuticals AG
Phase 2
54
Bangalore, Mumbai, New Delhi, Hyderabad, Kanpur, Lucknow
2024-04-17
Recruiting
AstraZeneca
Phase 3
3,850
Ahmedabad, Ajmer, Amritsar, Bangalore, Belagavi, Coimbatore, Dehradun, Delhi
2024-04-12
Active, closed
AstraZeneca
Phase 3
2,554
Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Dehradun, Hyderabad, Kolkata
2024-03-29
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Bangalore, Bhubaneswar, Erandwane, Hyderabad, Jaipur, Mumbai, Sūrat, Udaipur
2024-03-12
Recruiting
Rhizen Pharmaceuticals SA
Phase 2
40
Vijayawada, Bangalore, Mumbai, Pune, Madurai, Hyderabad, Kolkata
2024-03-04
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Hyderabad, Bangalore, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai, Kolkata
2024-02-28
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Bangalore, Haryāna, Hyderabad, Kolkata, New Delhi, Pune, Thiruvananthapuram
2024-02-05
Recruiting
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Ahmedabad, Bangalore, Bathinda, Chandigarh, Delhi, Gurugram, Hyderabad, Jabalpur
2024-01-10
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Gandhinagar, Gurugramam, Jhajjar, Bangalore, Mysuru, Navi Mumbai, Pune, Delhi
2023-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Bangalore, Mysore
2023-12-07
Active, closed
AstraZeneca
Phase 3
1,898
Bangalore, Calicut, Kanpur, Kolkata, Nagpur, New Delhi, Pune, Vadodara
2023-11-21
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Ahmedabad, Bangalore, Belagavi, Mysore, Nagpur, Nashik, New Delhi, Bikaner
2023-11-15
Active, closed
AstraZeneca
Phase 3
1,835
Bangalore, Belagavi, Delhi, Nadiād, New Delhi
2023-11-07
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Gandhinagar, Bangalore, Pune, Hyderabad
2023-11-01
Active, closed
University of California, San Francisco
Not applicable
800
Bangalore
2023-10-12
Active, closed
AstraZeneca
Phase 3
5,511
Ansārinagar, Bangalore, Dehradun, Delhi, Kolkata, Kozhikode, Mumbai, Mysuru
2023-10-05
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bangalore, Nagpur, Pune, New Delhi, Hyderabad
2023-10-02
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
50
Vijayawada, Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Bangalore, Mysore
2023-09-05
Recruiting
P+F Products + Features GmbH
Not applicable
267
Bangalore, Gūrgaon, Jaipur, Kochi, Vellore
2023-07-03
Active, closed
Alumis Inc
Phase 2
408
New Delhi, Ahmedabad, Bangalore, Bengaluru, Chandigarh, Haryāna, Jaipur, Lucknow
2023-06-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Chandigarh, Bangalore, Kochi, Kolhāpur, Nagpur, Pune, Bhubaneswar, Kolkata
2023-06-22
Active, closed
Eli Lilly and Company
Phase 3
3,127
Guntur, Bangalore, Mysore, Nagpur, Pune
2023-06-05
Active, closed
Bristol-Myers Squibb
Phase 4
85
Ahmedabad, New Delhi, Kolkata, Assam, Bangalore, Chandigarh, Delhi, Hyderabad
2023-06-05
Active, closed
AstraZeneca
Observational
712
Gurugram, New Delhi, Hyderabad, Bangalore, Chennai, Kolkata, Mumbai, Pune
2023-04-20
Recruiting
Pfizer
Phase 2
48
Bangalore, Lucknow, Kolkata
2023-04-18
Active, closed
TrEatment Approach in the Multimodal Era Registry
NCT05629052Chronic Thromboembolic Pulmonary Hypertension, CTEPH
International CTEPH Association
Observational
1,000
Bangalore
2023-04-12
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Aligarh, Amritsar, Bangalore, Belagavi, Bengaluru, Bikaner, Chennai, Chhatrapati Sambhajinagar
2023-04-11
Recruiting
AstraZeneca
Phase 3
4,300
Bangalore, Belagavi, Bhubaneswar, Hubli, Hyderabad, Jaipur, Kolkata, Mumbai
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Bangalore, Chandigarh, Gurugram, Kolkata, Mumbai, Pune
2023-03-23
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Guntur, Ahmedabad, Bangalore, Belagavi, Mangalore, Manipal, Mysore, Kochi
2023-03-09
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Ahmedabad, Ajmer, Anand, Bangalore, Belagavi, Bhubaneswar, Bikaner, Chennai
2023-02-15
Active, closed
Sanofi
Phase 3
91
Bangalore, Bhubaneswar, Pune-411011, Punjab, Vellore
2023-02-01
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Hyderabad, Secunderabad, Ahmedabad, Rajkot, Surat, Vadodara, Gurgaon, Bangalore
2023-01-16
Recruiting
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195Encephalopathy, Erythropoietin, Newborn Asphyxia
DrugErythropoietin
Imperial College London
Phase 3
504
Bangalore, Chennai, Chhatrapati Sambhajinagar, Hubli, Mumbai
2022-12-31
By invitation
Tolmar Inc.
Phase 3
250
Surat, Bangalore, Bengaluru, Mysore, Nagpur, Pune, Erode, Varanasi
2022-12-28
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Hyderabad, Kochi, Rudrapur, Ahmedabad, Ajmer, Bangalore, Bhubaneswar, Chandigarh
2022-12-27
Active, closed
Viatris Innovation GmbH
Phase 3
470
Ahmedabad, Bangalore, Chennai, Hyderabad, Jaipur, Nagpur, Nashik, Pune
2022-12-13
Active, closed
Celcuity Inc
Phase 3
701
Jaipur, Bangalore, Chandigarh, Kolkata, Navi Mumbai, Vellore
2022-12-08
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Chandigarh, Chennai, Hyderabad, Kanpur
2022-10-04
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bangalore, Bhubaneswar, Jaipur, New Delhi, Secunderabad, Surat
2022-09-19
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Ahmedabad, Bangalore, Pune, New Delhi
2022-08-04
Active, closed
Hoffmann-La Roche
Phase 3
922
Bangalore, Mumbai, Pune, New Delhi, Kolkata
2022-07-18
Active, closed
Novartis Pharmaceuticals
Phase 3
452
Bangalore, Secunderabad, Lucknow, Chandigarh
2022-07-14
Active, closed
Novartis Pharmaceuticals
Phase 3
610
Bangalore, New Delhi, Chennai, Coimbatore, Lucknow, Dehradun
2022-07-08
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
Chandigarh, Ahmedabad, Bangalore, Bhubaneswar, Bikaner, Noida
2022-06-30
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
529
Surat, Belagavi, Hubli, Pune, Bangalore, Chennai, Secunderabad, Sevilla
2022-06-30
Active, closed
Glenmark Specialty S.A.
Phase 1
320
Vijayawada, Visakhapatnam, Gurgaon, Bangalore, Bengaluru, Kannur, Chhatrapati Sambhajinagar, Mumbai
2022-06-28
Active, closed
Celgene
Phase 3
939
Hyderabad, Bangalore, Ernākulam, Mumbai, Kolkata, Puducherry
2022-06-23
Active, closed
AstraZeneca
Phase 3
644
Bangalore, Jaipur, Kolkata, Nagpur, Nashik, New Delhi, Puducherry, Vadodara
2022-05-16
Active, closed
AstraZeneca
Phase 3
760
Ahmedabad, Bangalore, Delhi, Hyderabad, Jaipur, Kolkata, Mumbai, New Delhi
2022-03-28
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Ahmedabad, Bangalore, Chandigarh
2022-03-16
Active, closed
AstraZeneca
Phase 3
791
Ahmedabad, Bangalore, Delhi, Howrah, Hyderabad, Jaipur, Kolkata, Marg Jaipur
2022-02-18
Recruiting
Acetazolamide for Treatment Resistant Schizophrenia
NCT04887792Schizophrenia, Schizo Affective Disorder
DrugAcetazolamide
Vishwajit Nimgaonkar, MD PhD
Phase 1/2
60
Bangalore
2022-02-01
Active, closed
ITM Solucin GmbH
Phase 3
259
Bangalore, New Delhi, Mumbai
2021-12-21
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Bangalore, Chennai, Madurai, Mumbai, Nashik, New Delhi, Pune, Vijayawada
2021-12-10
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Bangalore, Alappuzha, Trivandrum, New Delhi, Puducherry
2021-11-22
Recruiting
Biotech Healthcare Holding Gmbh
Not applicable
138
Bangalore, Chennai
2021-11-22
Active, closed
Immunic AG
Phase 3
1,121
Bangalore, Mangalore, Nagpur, New Delhi, Pune, Shimla, Varanasi
2021-11-18
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Bangalore, Gurugram, Kolkata, Mumbai, Nashik, New Delhi, Pune, Thane
2021-11-17
Active, closed
AstraZeneca
Phase 3
148
Bangalore, Belagavi, Jaipur, Mysore, Nashik
2021-10-28
Active, closed
AstraZeneca
Phase 3
454
Bangalore, Delhi, Hyderabad, Mumbai, Nashik
2021-10-28
Recruiting
A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses
NCT06839898Myopia, Moderate, Myopic Astigmatism, Myopia, Degenerative
Biotech Healthcare Holding Gmbh
Not applicable
172
Bangalore
2021-10-10
Active, closed
Eli Lilly and Company
Phase 3
874
Bangalore, Thiruvananthapuram, Mumbai, Nagpur, Nashik, Pune, Hyderabad
2021-10-04
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Bangalore, New Delhi, Hyderabad
2021-09-20
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Ahmedabad, Aligarh, Bangalore, Bathinda, Belagavi, Bhubaneswar, Bikaner, Chennai
2021-08-14
Recruiting
Meyer Children's Hospital IRCCS
Observational
103
Bangalore, Chandigarh, Chennai, Kochi, Kolkata
2021-07-13
Active, closed
AstraZeneca
Phase 3
893
Bangalore, Mohali, Mysuru, Nagpur, New Delhi, Vadodara, Varanasi
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Ahmedabad, Bangalore, Mumbai, Nashik, Pune, New Delhi, North WEST Delhi, Ratnagiri Kilminnal
2021-05-04
Active, closed
AstraZeneca
Phase 3
1,157
Ahmedabad, Bangalore, Bengaluru, Calicut, Gūrgaon, Mysuru, Nashik, New Delhi
2021-04-26
Active, closed
Geron Corporation
Phase 3
327
Surat, Bangalore, Bengaluru, New Delhi, Gūrgaon, Bhubaneswar, Kolkata, Pune
2021-04-12
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
Mumbai, Hyderabad, Bangalore, Cutack, New Delhi
2021-01-29
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Surat, Bangalore, Mumbai, Nashik, New Delhi, Hyderabad
2020-12-22
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Amravati, Bangalore, Bikaner, Nashik, New Delhi, Patna, Pune
2020-12-07
Active, closed
Amgen
Phase 3
135
Bangalore
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ahemdabad, Ahmedabad, Bangalore, Belagavi, Chhatrapati Sambhajinagar, Howrah, Hyderabad, Jaipur
2020-12-02
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Nagpur, Hyderabad, Bangalore, Lucknow, Manipal, Nashik, Pune, Surat
2020-10-15
Active, closed
Acerta Pharma BV
Phase 3
611
Bangalore, Delhi, Kochi, Mumbai, Nashik, Pune
2020-10-08
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 3
615
Bangalore, Bengaluru, Delhi, Mohali, Mumbai, Noida, Pune
2020-08-25
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Bangalore, Chandigarh
2020-08-06
Active, closed
AstraZeneca
Phase 3
1,012
Ahmedabad, Bangalore, Delhi, Faridabad, Kanpur, Kolkata, Madurai, Manipal
2020-07-13
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
296
Surat, Bangalore, Belagavi, Hubli, Pune, Hyderabad, Lucknow, Kochi
2020-07-01
Active, closed
Actelion
Phase 3
935
Ahmedabad, Bangalore, Chengalpetu, Coimbatore, Durgapur, Hyderabad, Hyderbad, Kolkata
2020-06-30
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Bangalore, Pune, Jaipur, Ranipet
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Bangalore, Pune, New Dehli, Ranipet, New Delhi
2019-10-21
Recruiting
Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
NCT03991728Temporomandibular Joint Disorders
AO Innovation Translation Center
Observational
200
Bangalore, New Delhi
2019-10-15
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Hyderabad, Ahmedabad, Bangalore, Gūrgaon, New Delhi
2019-10-03
Active, closed
AstraZeneca
Phase 3
923
Bangalore, Gūrgaon, Kolkata, Mumbai, Mysuru, Nagpur, Nashik, New Delhi
2019-06-25
Recruiting
Population Health Research Institute
Phase 4
2,270
North Guwāhāti, Ahmedabad, Bangalore, Alappuzha, Thrissur, Puducherry, Pune, Thiruvananthapuram
2019-06-14
Active, closed
Rakuten Medical, Inc.
Phase 3
135
Vadodara, Bangalore, Kochi, Chennai, Hyderabad, Kolkata, Mumbai
2019-05-09
Active, closed
Novo Nordisk A/S
Phase 3
1,500
Guntur, Surat, Bangalore, Kochi, Thiruvananthapuram, Thiruvnanthapuram, Mumbai, Nagpur
2019-05-08
Recruiting
Amgen
Phase 3
56
Bangalore, Belagavi, New Delhi, Kolkata
2019-04-29
Active, closed
AstraZeneca
Phase 2
367
Bangalore, Chennai, Kolkata, New Delhi
2019-01-09
Active, closed
AstraZeneca
Phase 3
724
Bangalore, Bengaluru, Hyderabad, Kolkata, Madurai, Mumbai, Nashik, Pune
2018-11-30
Active, closed
AstraZeneca
Phase 3
407
Bangalore, Bengaluru, Karamsad, Kolkata, Nashik, Vadodara
2018-11-27
Active, closed
Ottawa Heart Institute Research Corporation
Not applicable
176
Bangalore, New Delhi
2018-09-01
Active, closed
AstraZeneca
Phase 3
216
Bangalore, Gūrgaon, Hubli, Karamsad, Kolkata, Nashik, New Delhi
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Ahmedabad, Bangalore, Hyderabad, Jaipur, Ludhiana, Nagpur, Noida, Pune
2018-07-18
Not yet open
Composite Interceptive Med Science
Not applicable
40
Bangalore
2018-05-30
Active, closed
AstraZeneca
Phase 3
1,324
Bangalore, Bhubneshwar, Chennai, Hubli, Hyderabad, Karmsad, Mumbai, Nashik
2017-10-11
Active, closed
Eli Lilly and Company
Phase 3
5,637
Hyderabad, Ahmedabad, Vadodara, Gurgaon, Bangalore, Trivandrum, Mumbai, Nashik
2017-07-12
Active, closed
Pfizer
Phase 3
296
Gurugram, Bangalore, Pune
2017-04-27
Active, closed
Eli Lilly and Company
Phase 3
463
Ahmedabad, Bangalore, Mumbai, Pune, New Delhi, Ranipet, Kolkata
2016-12-05
Active, closed
AstraZeneca
Phase 3
953
Ahmedabad, Bangalore, Chennai, Gūrgaon, Karamsad, New Delhi
2015-11-03
Active, closed
McMaster University
Not applicable
5,000
Sītāpura, Bengaluru, Bangalore, Hyderabad
2015-10-21
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Bangalore, Kolkata, Mira Road (East), Nadiād
2015-04-22
Active, closed
Gilead Sciences
Phase 3
90
Surat, Gurgaon, Nagpur, Jaipur, Lucknow, Bangalore
2012-12-06
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Jaipur, Hyderabad, Bangalore, Bengaluru, Chennai, Gūrgaon, Kochi, New Delhi
2012-01
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Children's Hospital of Philadelphia
Observational
150,000
Bengaluru, Bangalore
2010-03
Recruiting
Prospective Urban Rural Epidemiology Study
NCT03225586Cardiovascular Diseases, Risk Factor, Cardiovascular, Health Behavior, Environmental Exposure
Population Health Research Institute
Observational
200,000
Bangalore, Thiruvananthapuram, Jaipur, Chennai, Chandigarh
2002-01-01
Recruiting
Medtronic
Observational
20,000
Bangalore, Chennai, Gūrgaon, Hyderabad, Jaipur, Kochi, New Delhi, Vadapalani
1983-01
Rows per page Showing 1–199 of 199
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-india/city/bangalore

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,120 studies in total at the last sync on 07 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 199 of those studies with a site in Bangalore.

How many clinical trials are recruiting in Bangalore?

92 of the 199 studies on this page are recruiting new participants as of the 07 Nov 2026, 03:16 UTC sync. A further 13 have not yet opened recruitment, 88 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bangalore), 199 studies
PhaseStudiesRecruitingShare
Phase 31254862.8%
Not applicable241112.1%
Observational15107.5%
Phase 21587.5%
Phase 4954.5%
Phase 1653%
Phase 2/3442%
Phase 1/2110.5%

Most active sponsors

Lead sponsors with the most studies (Bangalore)
Lead sponsorStudiesRecruiting
AstraZeneca4120
Eli Lilly and Company165
Novartis Pharmaceuticals114
Novo Nordisk A/S116
Janssen Research & Development, LLC91
Pfizer64
Boehringer Ingelheim54
Bristol-Myers Squibb52
Amgen31
Bioagile Therapeutics Pvt. Ltd.30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.